| 000 | 01784 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513134006.0 | ||
| 264 | 0 | _c19980218 | |
| 008 | 199802s 0 0 eng d | ||
| 022 | _a0013-7227 | ||
| 024 | 7 |
_a10.1210/endo.139.2.5753 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchwartz, Z | |
| 245 | 0 | 0 |
_aThe synergistic effects of vitamin D metabolites and transforming growth factor-beta on costochondral chondrocytes are mediated by increases in protein kinase C activity involving two separate pathways. _h[electronic resource] |
| 260 |
_bEndocrinology _cFeb 1998 |
||
| 300 |
_a534-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a24,25-Dihydroxyvitamin D 3 _xpharmacology |
| 650 | 0 | 4 |
_aAlkaline Phosphatase _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcitriol _xpharmacology |
| 650 | 0 | 4 |
_aCartilage _xcytology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCholera Toxin _xpharmacology |
| 650 | 0 | 4 |
_aChondrocytes _xdrug effects |
| 650 | 0 | 4 |
_aDiacylglycerol Kinase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProtein Kinase C _xdrug effects |
| 650 | 0 | 4 |
_aPyrimidinones _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aRibs _xdrug effects |
| 650 | 0 | 4 |
_aSulfates _xmetabolism |
| 650 | 0 | 4 |
_aThiazoles _xpharmacology |
| 650 | 0 | 4 |
_aThymidine _xmetabolism |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xpharmacology |
| 650 | 0 | 4 |
_aVirulence Factors, Bordetella _xpharmacology |
| 700 | 1 | _aSylvia, V L | |
| 700 | 1 | _aDean, D D | |
| 700 | 1 | _aBoyan, B D | |
| 773 | 0 |
_tEndocrinology _gvol. 139 _gno. 2 _gp. 534-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/endo.139.2.5753 _zAvailable from publisher's website |
| 999 |
_c9418744 _d9418744 |
||